Delivery Order SPE2DB22D2206-SPE2DB24FKD16
Award Date
9/4/24
Potential Completion Date
9/5/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $4,647.12 firm fixed price contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product. The contract has an ultimate completion date of April 16, 2024. Amerisourcebergen, through its Corporate Office Division, is a well-established supplier of pharmaceutical products and medical supplies to the U.S....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $4,647.12 firm-fixed-price delivery order is for the supply of 4,566,077,237 units of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The award has an ultimate completion date of October 11, 2024 and is not designated as a set-aside contract. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor in the United States. The contract, valued at $25,621.15, is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. This is a firm fixed-price delivery order contract with a completion date of August 22, 2024. The contract is not designated as a set-aside. Amerisourcebergen, through its Corporate Office Division,...
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product, with a completion date of June 10, 2024. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $14,658 firm-fixed-price Delivery Order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with an ultimate completion date of September 19, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,966.15 Firm Fixed Price delivery order contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The $4,647.12 delivery order contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, to the DLA. The contract is a firm fixed-price agreement with a completion date of July 12, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $4,647.12 firm fixed price delivery order is for the supply of Monovisc 88 mg/4 ml syringes, a specialized pharmaceutical product. This award is under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with a potential value of $999,999,999.00...
This federal contract award, valued at $4,906.14, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The award is for the delivery of 4,565,477,796 units of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with an ultimate completion date of August 19, 2024. This is a firm fixed-price delivery order contract with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $4,647.12 firm fixed price delivery order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a specialty pharmaceutical product. The award is associated with a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 through...